Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6001 to 6015 of 7691 results

  1. Vasopressors to manage delayed cerebral ischaemia: What is the clinical and cost effectiveness of vasopressors to manage delayed cerebral ischaemia in people with aneurysmal subarachnoid haemorrhage?

    Recommendation ID NG228/11 Question Vasopressors to manage delayed cerebral ischaemia: What is the clinical and cost effectiveness of vasopressors

    Research recommendation
    Published
    12 December 2022

  2. Dose strategies for people who are obese:- What is the clinical and cost effectiveness of weight-based dose-adjustment strategies of lowmolecular-weight heparin (LMWH) compared with fixed-dose strategies of LMWH for preventing VTE in people who are very obese (BMI over 35) who are admitted to hospital or having day procedures (including surgery and chemotherapy)?

    Recommendation ID NG89/2 Question Dose strategies for people who are obese:- What is the clinical and cost effectiveness of weight-based

    Research recommendation
    Published
    15 November 2018

  3. What is the clinical effectiveness and rate of adverse events of statin therapy using atorvastatin 20 mg per day compared with atorvastatin 40 mg per day and atorvastatin 80 mg per day in people without established CVD?

    Recommendation ID CG181/5 Question What is the clinical effectiveness and rate of adverse events of statin therapy using atorvastatin 20

    Research recommendation
    Published
    9 June 2015

  4. What is the clinical effectiveness and safety of vitamin D for treating COVID-19 in children, young people and adults?

    Recommendation ID NG191/19 Question What is the clinical effectiveness and safety of vitamin D for treating COVID-19 in children, young

    Research recommendation
    Published
    14 July 2022

  5. Oral teicoplanin compared with oral vancomycin or oral fidaxomicin for treating Clostridioides difficile infection: What is the clinical effectiveness, cost effectiveness and safety of oral teicoplanin 100 mg to 200 mg twice a day for 7 to 14 days compared with oral vancomycin or oral fidaxomicin for treating C. difficile infection in adults?

    Recommendation ID NG199/1 Question Oral teicoplanin compared with oral vancomycin or oral fidaxomicin for treating Clostridioides difficile

    Research recommendation
    Published
    12 August 2021

  6. Psychological and pharmacological interventions for people with paraphilic disorders:- What is the clinical effectiveness, cost effectiveness and safety of specific psychological and pharmacological interventions both in and out of prison among people with paraphilic disorders?

    Recommendation ID NG66/1 Question Psychological and pharmacological interventions for people with paraphilic disorders:- What is the clinical

    Research recommendation
    Published
    16 May 2017

  7. What is the clinical effectiveness of continuous positive pressure ventilation compared with usual care in patients with community-acquired pneumonia and type I respiratory failure without a history of chronic obstructive pulmonary disease?

    Recommendation ID CG191/3 Question What is the clinical effectiveness of continuous positive pressure ventilation compared with usual care

    Research recommendation
    Published
    9 June 2015

  8. What is the clinical effectiveness of using the VivaScope 1500 and 3000 imaging systems to define margins of lentigo maligna and basal cell carcinoma compared with histological margins determined by Mohs surgery?

    Recommendation ID DG19/4 Question What is the clinical effectiveness of using the VivaScope 1500 and 3000 imaging systems to define margins

    Research recommendation
    Published
    12 January 2016

  9. What is the comparative clinical and cost effectiveness of pharmacological and psychosocial interventions for anxiety disorders in autistic children and young people?

    Recommendation ID CG170/3 Question What is the comparative clinical and cost effectiveness of pharmacological and psychosocial interventions

    Research recommendation
    Published
    10 August 2021

  10. What is the comparative effectiveness and cost effectiveness of exercise referral schemes compared with other interventions that aim to help people to become more physically active? Relative effectiveness and cost effectiveness should be compared in controlled trials.

    Recommendation ID PH54/4 Question What is the comparative effectiveness and cost effectiveness of exercise referral schemes compared with

    Research recommendation
    Published
    9 June 2015

  11. Pharmacological management of peripheral spondyloarthritis:- What is the comparative effectiveness and cost effectiveness of standard DMARDs for managing peripheral spondyloarthritis, and is this effectiveness affected by differences in dose escalation protocols?

    Recommendation ID NG65/4 Question Pharmacological management of peripheral spondyloarthritis:- What is the comparative effectiveness and

    Research recommendation
    Published
    4 May 2017

  12. Prophylactic antibiotics for preventing exacerbations:- What is the comparative effectiveness of different antibiotics, doses and regimens of prophylactic antibiotics for people with stable COPD who are at high risk of exacerbations?

    Recommendation ID NG115/8 Question Prophylactic antibiotics for preventing exacerbations:- What is the comparative effectiveness of different

    Research recommendation
    Published
    13 February 2019

  13. Prophylactic antibiotics for preventing exacerbations:- What is the comparative effectiveness of seasonal versus continuous prophylactic antibiotics for people with stable COPD who are at high risk of exacerbations?

    Recommendation ID NG115/9 Question Prophylactic antibiotics for preventing exacerbations:- What is the comparative effectiveness of seasonal

    Research recommendation
    Published
    13 February 2019

  14. Rate-control drug treatment for people aged 75 and over with atrial fibrillation: What is the comparative effectiveness of the 3 main drug classes used for rate control (beta‑blockers, calcium‑channel blockers and digoxin) in people aged 75 and over with atrial fibrillation in controlling symptoms, improving quality of life and reducing morbidity and mortality?

    Recommendation ID NG196/6 Question Rate-control drug treatment for people aged 75 and over with atrial fibrillation: What is the comparative

    Research recommendation
    Published
    10 August 2021

  15. Psychologically informed environments: What is the effectiveness and acceptability of clinical psychology-led psychologically informed environments and psychological approaches for people experiencing homelessness?

    Recommendation ID NG214/01 Question Psychologically informed environments: What is the effectiveness and acceptability of clinical psychology-led

    Research recommendation
    Published
    8 April 2022